Salient Capital Advisors’s Unilever NV New York Registry Shares UN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-28,509
Closed -$1.58M 210
2017
Q2
$1.58M Sell
28,509
-11,320
-28% -$611K 0.03% 106
2017
Q1
$1.98M Buy
39,829
+4,980
+14% +$223K 0.04% 106
2016
Q4
$1.43M Buy
34,849
+11,340
+48% +$469K 0.03% 108
2016
Q3
$1.08M Sell
23,509
-8,170
-26% -$377K 0.02% 114
2016
Q2
$1.49M Buy
31,679
+880
+3% +$39.4K 0.03% 109
2016
Q1
$1.38M Buy
30,799
+13,470
+78% +$580K 0.04% 105
2015
Q4
$751K Buy
+17,329
New +$759K 0.02% 140
2015
Q3
Sell
-5,276
Closed -$221K 277
2015
Q2
$221K Buy
5,276
+56
+1% +$2.42K ﹤0.01% 247
2015
Q1
$218K Hold
5,220
﹤0.01% 233
2014
Q4
$204K Hold
5,220
﹤0.01% 228
2014
Q3
$207K Hold
5,220
﹤0.01% 219
2014
Q2
$228K Sell
5,220
-200
-4% -$8.58K ﹤0.01% 215
2014
Q1
$223K Hold
5,420
0.01% 206
2013
Q4
$218K Buy
5,420
+20
+0.4% +$778 0.01% 197
2013
Q3
$204K Buy
+5,400
New +$213K 0.01% 156

Other funds holding UN

Salient Capital Advisors's UN Position: Q3 2017 in Review

Salient Capital Advisors sold out of Unilever NV New York Registry Shares (UN) in Q3 2017, closing a stake of 28,509 shares — an estimated $1.58M sold.

Salient Capital Advisors first reported a position in UN in Q3 2013 and held it in 15 quarters. The position peaked at $1.98M in Q1 2017. 516 funds tracked by Wall St. Rank hold UN as of Q3 2017.

  • Salient Capital Advisors reported no remaining Unilever NV New York Registry Shares position as of Q3 2017 after selling out during the quarter.
  • Salient Capital Advisors sold 28,509 Unilever NV New York Registry Shares shares in Q3 2017, an estimated $1.58M.
  • Salient Capital Advisors first reported a position in Unilever NV New York Registry Shares in Q3 2013 and held it in 15 quarters.
  • Salient Capital Advisors's Unilever NV New York Registry Shares position peaked at $1.98M in Q1 2017.
  • 516 funds tracked by Wall St. Rank held Unilever NV New York Registry Shares as of Q3 2017.

Based on Salient Capital Advisors's 13F filing for Q3 2017, filed 6 Nov 2017.